Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis.

Littlewood JM, Connett GJ, Sander-Struckmeier S, Henniges F; Creon 40,000 Study Group.

Expert Opin Drug Saf. 2011 Mar;10(2):197-203. doi: 10.1517/14740338.2011.552499.

PMID:
21342076
2.

Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.

Littlewood JM, Wolfe SP, Conway SP.

Pediatr Pulmonol. 2006 Jan;41(1):35-49. Review.

PMID:
16288483
3.

European cystic fibrosis society consensus on standards--a roadmap to "best care".

Littlewood JM.

J Cyst Fibros. 2005 Mar;4(1):1-5. Epub 2005 Jan 25. No abstract available.

4.

Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.

Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM.

J Cyst Fibros. 2003 Mar;2(1):29-34.

5.

Scoliosis in cystic fibrosis: is it idiopathic?

Kumar N, Balachandran S, Millner PA, Littlewood JM, Conway SP, Dickson RA.

Spine (Phila Pa 1976). 2004 Sep 15;29(18):1990-5. Review.

PMID:
15371699
6.

Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.

Lee TW, Brownlee KG, Denton M, Littlewood JM, Conway SP.

Pediatr Pulmonol. 2004 Feb;37(2):104-10.

PMID:
14730654
7.

Newborn screening programmes for cystic fibrosis.

Southern KW, Littlewood JM.

Paediatr Respir Rev. 2003 Dec;4(4):299-305. Review.

PMID:
14629952
8.

Good care for people with cystic fibrosis.

Littlewood JM.

Paediatr Respir Rev. 2000 Jun;1(2):179-89. Review.

PMID:
12531112
9.

Elusiveness of cystic-fibrosis treatment.

Littlewood JM, Govan JR.

Lancet. 2001 Feb 24;357(9256):633-4. No abstract available.

PMID:
11558508
10.

Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium.

Denton M, Hall MJ, Todd NJ, Kerr KG, Littlewood JM.

Clin Microbiol Infect. 2000 Jul;6(7):397-8. No abstract available.

11.

Control of malabsorption in cystic fibrosis.

Littlewood JM, Wolfe SP.

Paediatr Drugs. 2000 May-Jun;2(3):205-22. Review. Erratum in: Paediatr Drugs 2000 Jul-Aug;2(4):252.

PMID:
10937471
12.

A ten year review of colomycin.

Littlewood JM, Koch C, Lambert PA, Høiby N, Elborn JS, Conway SP, Dinwiddie R, Duncan-Skingle F.

Respir Med. 2000 Jul;94(7):632-40. Review. No abstract available.

13.

Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis.

Cade A, Walters MP, McGinley N, Firth J, Brownlee KG, Conway SP, Littlewood JM.

Pediatr Pulmonol. 2000 Mar;29(3):172-6.

PMID:
10686036
14.

Update on intestinal strictures.

Littlewood JM.

J R Soc Med. 1999;92 Suppl 37:41-9. Review. No abstract available.

15.

Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements.

Ansari EA, Sahni K, Etherington C, Morton A, Conway SP, Moya E, Littlewood JM.

Br J Ophthalmol. 1999 Jun;83(6):688-91.

16.

Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. The UK Cystic Fibrosis Survey Management Committee.

Lewis PA, Morison S, Dodge JA, Geddes D, Coles EC, Russell G, Littlewood JM, Scott MT.

Thorax. 1999 May;54(5):420-2.

17.

Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.

Ramsden WH, Moya EF, Littlewood JM.

Arch Dis Child. 1998 Oct;79(4):339-43.

18.

Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations.

Walters MP, Littlewood JM.

J Pediatr Gastroenterol Nutr. 1998 Sep;27(3):296-300.

PMID:
9740200
19.
20.

High serum immunoreactive trypsin not caused by cystic fibrosis.

Moya EF, Brocklebank JT, Littlewood JM, O'Connor LM, Penney MD.

Arch Dis Child Fetal Neonatal Ed. 1998 Jan;78(1):F78. No abstract available.

21.

Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee.

Morison S, Dodge JA, Cole TJ, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT.

Arch Dis Child. 1997 Dec;77(6):497-500.

22.

Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee.

Dodge JA, Morison S, Lewis PA, Coles EC, Geddes D, Russell G, Littlewood JM, Scott MT.

Arch Dis Child. 1997 Dec;77(6):493-6.

23.

rhDNase in cystic fibrosis.

Conway SP, Littlewood JM.

Br J Hosp Med. 1997 Apr 16-May 6;57(8):371-2. Review.

PMID:
9274660
24.

A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.

Gill DR, Southern KW, Mofford KA, Seddon T, Huang L, Sorgi F, Thomson A, MacVinish LJ, Ratcliff R, Bilton D, Lane DJ, Littlewood JM, Webb AK, Middleton PG, Colledge WH, Cuthbert AW, Evans MJ, Higgins CF, Hyde SC.

Gene Ther. 1997 Mar;4(3):199-209.

25.

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis unit.

Denton M, Littlewood JM, Brownlee KG, Conway SP, Todd NJ.

Lancet. 1996 Dec 7;348(9041):1596-7. No abstract available.

PMID:
8950918
26.

Pancreatin preparations used in the treatment of cystic fibrosis--lipase content and in vitro release.

Walters MP, Littlewood JM.

Aliment Pharmacol Ther. 1996 Jun;10(3):433-40.

PMID:
8791974
27.

Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients.

Denton M, Todd NJ, Littlewood JM.

Eur J Clin Microbiol Infect Dis. 1996 May;15(5):402-5.

PMID:
8793400
28.

Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice.

Littlewood JM.

Postgrad Med J. 1996 Mar;72 Suppl 2:S56-62; discussion S59-62. No abstract available.

PMID:
8869184
29.

Stable isotope studies of pancreatic enzyme release in vivo.

Seal S, McClean P, Walters M, Wolfe SP, Harding M, Coward W, Littlewood JM.

Postgrad Med J. 1996 Mar;72 Suppl 2:S37-8. No abstract available.

PMID:
8869181
30.

Update on the United States epidemiology study.

Littlewood JM.

Postgrad Med J. 1996 Mar;72 Suppl 2:S6; discussion S7-10. No abstract available.

PMID:
8869178
31.

Fibrosing colonopathy in children with cystic fibrosis.

Littlewood JM.

Postgrad Med J. 1996 Mar;72(845):129-30. No abstract available.

32.

The role of hepatobiliary scintigraphy in cystic fibrosis.

O'Connor PJ, Southern KW, Bowler IM, Irving HC, Robinson PJ, Littlewood JM.

Hepatology. 1996 Feb;23(2):281-7.

PMID:
8591853
33.

Nebulised amiloride in respiratory exacerbations of cystic fibrosis: a randomised controlled trial.

Bowler IM, Kelman B, Worthington D, Littlewood JM, Watson A, Conway SP, Smye SW, James SL, Sheldon TA.

Arch Dis Child. 1995 Nov;73(5):427-30.

34.

Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment.

Bush A, Hodson ME, Geddes DM, Rosenthal M, Dinwiddie R, Wallis C, Stableforth DE, Conway SP, Littlewood JM.

BMJ. 1995 Jun 10;310(6993):1533. No abstract available.

35.

Coeliac disease in childhood.

Littlewood JM.

Baillieres Clin Gastroenterol. 1995 Jun;9(2):295-327. Review.

PMID:
7549029
36.

Colonic strictures in cystic fibrosis.

Green MR, Southern KW, Wolfe SP, Littlewood JM, Najmaldin AS, Wyatt JI.

Arch Dis Child. 1995 Feb;72(2):191. No abstract available.

37.

Abdominal pain in cystic fibrosis.

Littlewood JM.

J R Soc Med. 1995;88 Suppl 25:9-17. Review. No abstract available.

38.

Aspergillus fumigatus colonisation and population density of place of residence in cystic fibrosis.

Simmonds EJ, Littlewood JM, Hopwood V, Evans EG.

Arch Dis Child. 1994 Feb;70(2):139-40.

39.

Changes in nocturnal oximetry after treatment of exacerbations in cystic fibrosis.

Allen MB, Mellon AF, Simmonds EJ, Page RL, Littlewood JM.

Arch Dis Child. 1993 Aug;69(2):197-201.

40.

Aerosol antibiotic treatment in cystic fibrosis.

Littlewood JM, Smye SW, Cunliffe H.

Arch Dis Child. 1993 Jun;68(6):788-92. Review. No abstract available.

41.

Resting energy expenditure and substrate oxidation rates in cystic fibrosis.

Bowler IM, Green JH, Wolfe SP, Littlewood JM.

Arch Dis Child. 1993 Jun;68(6):754-9.

42.

A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis.

Bowler IM, Wolfe SP, Owens HM, Sheldon TA, Littlewood JM, Walters MP.

Arch Dis Child. 1993 Feb;68(2):227-30.

43.

Cystic fibrosis in Asians.

Bowler IM, Estlin EJ, Littlewood JM.

Arch Dis Child. 1993 Jan;68(1):120-2.

44.

Cystic fibrosis: gastrointestinal complications.

Littlewood JM.

Br Med Bull. 1992 Oct;48(4):847-59. Review.

PMID:
1458304
45.
46.

Episodic arthritis in cystic fibrosis.

Bowler IM, Littlewood JM.

Lancet. 1992 Jul 25;340(8813):244. No abstract available.

PMID:
1353166
47.

Management and response to treatment of Helicobacter pylori gastritis.

Mahony MJ, Wyatt JI, Littlewood JM.

Arch Dis Child. 1992 Jul;67(7):940-3.

48.

Measurement and prediction of drug solvent losses by evaporation from a jet nebuliser.

Smye SW, Jollie MI, Cunliffe H, Littlewood JM.

Clin Phys Physiol Meas. 1992 May;13(2):129-34.

PMID:
1499255
49.

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection.

Conway SP, Simmonds EJ, Littlewood JM.

Thorax. 1992 Feb;47(2):112-4.

50.

Gastrointestinal complications in cystic fibrosis.

Littlewood JM.

J R Soc Med. 1992;85 Suppl 19:13-9. Review. No abstract available.

Supplemental Content

Loading ...
Support Center